References

European Federation of Allergy and Airways Diseases Patients’ Associations. 2009. http//www.efanet.org/documents/EFACOPDBook.pdf (accessed 26 March 2012)

Council of the European Union. 2011. http//www.consilium.europa.eu/uedocs/cms_Data/docs/pressdata/en/lsa/126522.pdf (Accessed 26 March 2012)

EFA. 2010. http//www.efanet.org/documents/EFACOPDBook.pdf (accessed 26 March 2012)

Global Initiative for Chronic Obstructive Lung Disease. 2011. http//www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html (accessed 26 March 2012)

Ministry of Social Affairs and Health (Finland). 1998. http//www.flha.f/@Bin/28754/copd_eng.pdf (accessed 26 March 2012)

Chronic obstructive pulmonary disease: Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006; 61:(21)1043-7

Policymakers to prevent Europe from suffocating

06 April 2012
Volume 4 · Issue 4

Chronic obstructive pulmonary disease (COPD), is a progressive disease affecting almost 10% of all adults. Currently ranked at number six on the WHO’s mortality list, it is predicted to become the 3rd leading cause of death by 2030 despite remaining an unknown disease to many people. COPD is a condition leading to a constant degradation of lung functions, causing muscles and organs to slowly and steadily suffocate. Unlike asthma, COPD is an irreversible condition that can only be maintained meaning that prevention and a timely diagnosis, plus effective treatment, are all the more important in managing the condition.

In 2010, the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) launched its book on COPD in Europe – Sharing and Caring (Franchi, 2009) issuing a corresponding call to action (EFA, 2010) for Europe and the European Parliament, together with a broad coalition of healthcare, tobacco control and environment stakeholders to address the disease. The book features information on COPD from EFA member associations in 12 countries covering the epidemiology, economic burden, social impact, access to care, available support services, preventive measures and early diagnosis of the disease, as well as specific national successes as judged by patient groups.

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed